Skip to content

Research for near-infrared second window fluorescence imaging for liver tumor detection

Investigation for the feasibility and effectiveness of near-infrared second window fluorescence imaging for liver tumor detection

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022453
Enrollment
Unknown
Registered
2019-04-11
Start date
2017-07-31
Completion date
Unknown
Last updated
2019-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver tumor

Interventions

Sponsors

Institute of Automation, Chinese Academy of Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 80 years male and female; 2. Diagnosed as liver tumor and prepared to receive resection surgery; 3. Resection surgery is believed feasible, and no other treatments conducted in the previous; 4. Tumor number 1~3 lesions, tumor at stages B or C, without tumor cell widely diffused; 5. Liver function Child-Pugh A; 6. Well function of bone marrow; 7. Well function of kidney; 8. Approved to sigh the informed consent and able to receive the follow-up.

Exclusion criteria

Exclusion criteria: 1. Allergic to ICG; 2. Enrolled in other trials in the past 3 months; 3. Feeding milk or pregnant; 4. Received whole body chemical therapy in the past 4 weeks; 5. ICG R15 >= 40%; 6. Distant metastases discovered before the surgery; 7. NYHA functional class is greater than 2; 8. Refractory hypertension has lasted more than 12 months; 9. With active infection; 10. Uncontrollable diabetes; 11. In the time of receiving anticoagulant therapy.

Design outcomes

Primary

MeasureTime frame
Liver tumor number of intraoperative in vivo detection;Liver tumor number of ex vivo detection;

Countries

China

Contacts

Public ContactZhenhua Hu

Institute of Automation, Chinese Academy of Sciences

zhenhua.hu@ia.ac.cn+86 13581998316

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026